SkinMason Life Inc. – Trademark Portfolio

Entity Type: 11

SkinMason Life Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include SKIN MASON. The owner is based in Vancouver, BC.

#1603 - 289 Drake Street

Vancouver, BC V6B5Z5 , CA

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SkinMason Life Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does SkinMason Life Inc. have?

SkinMason Life Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending.

What trademark classes does SkinMason Life Inc. file in?

SkinMason Life Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SkinMason Life Inc.'s most well-known trademarks?

SkinMason Life Inc.'s registered trademark portfolio includes well-known marks such as SKIN MASON. These are among 1 currently registered trademark in the portfolio.

What is SkinMason Life Inc.'s trademark registration success rate?

SkinMason Life Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.